Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Konstantinos Iliodromitis, Sotiria G. Giotaki, Charalampos Kossyvakis, Konstantinos Raisakis, Andreas Kaoukis, Vaia Lambadiari, Dimitrios Avramides, Bernhard Reimers, Giulio Stefanini, Michael Cleman, Γεώργιος Γιαννόπουλος, Alexandra J. Lansky, Spyridon Deftereos
Topics & Concepts
MedicineAtrial fibrillationRandomized controlled trialClinical trialObservational studyIntensive care medicineClinical endpointType 2 diabetesDiabetes mellitusPharmacologyInternal medicineEndocrinologyDiabetes Treatment and ManagementAtrial Fibrillation Management and OutcomesPotassium and Related Disorders